Article Text

Download PDFPDF
Vaginal sarcoma: the Royal Marsden experience
  1. H. Y.S. Ngan,
  2. J. H. Shepherd,
  3. C. Fisher* and
  4. P. Blake
  1. * Department of Gynaecology, Department of Pathology and
  2. Department of Radiotherapy, Royal Marsden Hospital, London, UK
  1. Address for correspondence: H. Y. S. Ngan, Department of Gynaecology, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK.


Six patients with vaginal sarcoma are reported here. This clinicopathologic review confirms the poor prognosis of this disease. However, there were three 5-year survivors, all of whom had early stage disease and low to intermediate grade tumors. Apart from tumor grade, stage was of prognostic importance. Late recurrences at 5 and 21 years were noted in two of the three 5-year survivors. Neither chemotherapy nor radiotherapy were of use in the treatment of late stage or recurrent disease.

  • vaginal sarcoma.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.